BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3925943)

  • 1. Preparation and specificity of avian anti-GM2(NeuGc) ganglioside antiserum.
    Kasai N; Naiki M; Ariga T; Hirabayashi Y; Yu RK
    Biochem Biophys Res Commun; 1985 Jun; 129(2):334-41. PubMed ID: 3925943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific expression of unusual GM2 ganglioside with Hanganutziu-Deicher antigen activity on human colon cancers.
    Hirabayashi Y; Kasakura H; Matsumoto M; Higashi H; Kato S; Kasai N; Naiki M
    Jpn J Cancer Res; 1987 Mar; 78(3):251-60. PubMed ID: 3106281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody directed to a Hanganutziu-Deicher active ganglioside, GM2 (NeuGc).
    Sanai Y; Yamasaki M; Nagai Y
    Biochim Biophys Acta; 1988 Feb; 958(3):368-74. PubMed ID: 2449247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of anti-Neu-glycolyl-ganglioside antibodies by immunization with an anti-idiotype monoclonal antibody: A self versus non-self-matter.
    Hernández AM; Rodríguez M; López-Requena A; Beausoleil I; Pérez R; Vázquez AM
    Immunobiology; 2005; 210(1):11-21. PubMed ID: 16076030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisera against ganglioside GM2: immunochemical and immunohistological studies.
    Schwerer B; Lassmann H; Bernheimer H
    Neuropathol Appl Neurobiol; 1982; 8(3):217-26. PubMed ID: 6214725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of monoclonal antibodies directed to Hanganutziu-Deicher active gangliosides, N-glycolylneuraminic acid-containing gangliosides.
    Watarai S; Kushi Y; Shigeto R; Misawa N; Eishi Y; Handa S; Yasuda T
    J Biochem; 1995 May; 117(5):1062-9. PubMed ID: 8586620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Avian antisera to various gangliosides: detection by enzyme immunoassay.
    Miyoshi I; Fujii Y; Naiki M
    J Biochem; 1982 Jul; 92(1):89-94. PubMed ID: 6749835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of anti-GM4 antiserum and its assay by a solid-phase radioimmunoassay.
    Jacobson RI; Kasai N; Richards FF; Yu RK
    J Neuroimmunol; 1982 Nov; 3(3):225-35. PubMed ID: 7142381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic regulation of GM2 (NeuGc) expression in liver of mouse.
    Suzuki A; Hashimoto Y; Abe M; Kiuchi Y; Yamakawa T
    Adv Exp Med Biol; 1984; 174():263-72. PubMed ID: 6430047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of murine monoclonal antibodies specific for N-glycolylneuraminic acid-containing gangliosides.
    Ozawa H; Kawashima I; Tai T
    Arch Biochem Biophys; 1992 May; 294(2):427-33. PubMed ID: 1567198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of ganglioside expression in human melanoma cells: immunological and biochemical analysis.
    Kawashima I; Ozawa H; Kotani M; Suzuki M; Kawano T; Gomibuchi M; Tai T
    J Biochem; 1993 Aug; 114(2):186-93. PubMed ID: 8262898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of two murine monoclonal antibodies that can discriminate N-glycolyl and N-acetyl neuraminic acid residues of GM2 gangliosides.
    Miyake M; Ito M; Hitomi S; Ikeda S; Taki T; Kurata M; Hino A; Miyake N; Kannagi R
    Cancer Res; 1988 Nov; 48(21):6154-60. PubMed ID: 3167861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic regulation of GM2 expression in liver of mouse.
    Hashimoto Y; Otsuka H; Sudo K; Suzuki K; Suzuki A; Yamakawa T
    J Biochem; 1983 Mar; 93(3):895-901. PubMed ID: 6874670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines.
    Vrionis FD; Wikstrand CJ; Fredman P; Månsson JE; Svennerholm L; Bigner DD
    Cancer Res; 1989 Dec; 49(23):6645-51. PubMed ID: 2479468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two pathways for GM2(NeuGc) expression in mice: genetic analysis.
    Kono M; Sekine M; Nakamura K; Hashimoto Y; Seyama Y; Yamakawa T; Suzuki A
    J Biochem; 1991 Jan; 109(1):132-6. PubMed ID: 2016262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of monoclonal antibodies specific for two distinct steric portions of the glycolipid ganglio-N-triosylceramide (asialo GM2).
    Young WW; MacDonald EM; Nowinski RC; Hakomori SI
    J Exp Med; 1979 Oct; 150(4):1008-19. PubMed ID: 512581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of N-glycolyated gangliosides in non-small-cell lung cancer using GMR8 monoclonal antibody.
    Hayashi N; Chiba H; Kuronuma K; Go S; Hasegawa Y; Takahashi M; Gasa S; Watanabe A; Hasegawa T; Kuroki Y; Inokuchi J; Takahashi H
    Cancer Sci; 2013 Jan; 104(1):43-7. PubMed ID: 23004020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and properties of antibodies to GD3 and GM1 gangliosides.
    Kundu SK; Marcus DM; Veh RW
    J Neurochem; 1980 Jan; 34(1):184-8. PubMed ID: 6778957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies.
    Furukawa K; Yamaguchi H; Oettgen HF; Old LJ; Lloyd KO
    Cancer Res; 1989 Jan; 49(1):191-6. PubMed ID: 2908845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse liver gangliosides.
    Suzuki M; Nakamura K; Hashimoto Y; Suzuki A; Yamakawa T
    Carbohydr Res; 1986 Aug; 151():213-23. PubMed ID: 3768889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.